The Important Role of the Nuclearity, Rigidity, and Solubility of Phosphane Ligands in the Biological Activity of Gold(I) Complexes

Chemistry - A European Journal - Tập 24 Số 55 - Trang 14654-14667 - 2018
Noora Svahn1, Artur J. Moro2, Catarina Roma‐Rodrigues3, Rakesh Puttreddy4, Kari Rissanen4, Pedro V. Baptista3, Alexandra R. Fernandes3, João Carlos Lima2, Laura Rodrı́guez1,5
1Departament de Química Inorgànica i Orgànica, Secció de Química Inorgànica Universitat de Barcelona Martí i Franquès 1–11 08028 Barcelona Spain
2LAQV-REQUIMTE, Departamento de Química, CQFB, Universidade Nova de Lisboa, Monte de Caparica, Portugal
3UCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Campus de Caparica, 2829-516 Caparica, Portugal
4Department of Chemistry, Nanoscience Center University of Jyvaskyla P.O. Box 35 40014 Jyväskylä Finland
5Institut de Nanociència i Nanotecnologia (IN2UB), Universitat de Barcelona, 08028 Barcelona, Spain

Tóm tắt

AbstractA series of 4‐ethynylaniline gold(I) complexes containing monophosphane (1,3,5‐triaza‐7‐phosphaadamantane (pta; 2), 3,7‐diacetyl‐1,3,7‐triaza‐5‐phosphabicyclo[3.3.1]nonane (3), and PR3, with R=naphthyl (4), phenyl (5), and ethyl (6)) and diphosphane (bis(diphenylphosphino)acetylene (dppa; 7), trans‐1,2‐bis(diphenylphosphino)ethene (dppet; 8), 1,2‐bis(diphenylphosphino)ethane (dppe; 9), and 1,3‐bis(diphenylphosphino)propane (dppp; 10)) ligands have been synthesized and their efficiency against tumor cells evaluated. The cytotoxicity of complexes 210 was evaluated in human colorectal (HCT116) and ovarian (A2780) carcinoma as well as in normal human fibroblasts. All the complexes showed a higher antiproliferative effect in A2780 cells, with the cytotoxicity decreasing in the following order 5>6=9=10>8>2>4>7>3. Complex 4 stands out for its very high selectivity towards ovarian carcinoma cells (IC50=2.3 μm) compared with colorectal carcinoma and normal human fibroblasts (IC50>100 μm), which makes this complex very attractive for ovarian cancer therapy. Its cytotoxicity in these cells correlates with the induction of the apoptotic process and an increase of intracellular reactive oxygen species (ROS). The effects of the nuclearity, rigidity, and solubility of these complexes on their biological activity were also analyzed. X‐ray crystal structure determination allowed the identification of short N−H⋅⋅⋅π contacts as the main driving forces for the three‐dimensional packing in these molecules.

Từ khóa


Tài liệu tham khảo

10.1038/nrc2167

10.1016/j.ccr.2009.02.019

10.2174/187152011797927670

Nardon C., 2014, Anticancer Res., 34, 487

10.1039/C5CS00132C

10.1016/j.jinorgbio.2015.01.014

10.2174/187152011797927634

10.2174/187152011797927607

10.1021/jm060436a

10.1021/ic403011h

10.1016/S0010-8545(02)00048-6

10.1016/j.poly.2010.03.012

10.1002/anie.201202939

10.1002/ange.201202939

10.1016/j.ccr.2007.04.006

10.1016/j.ejmech.2018.01.065

10.2174/156802611798040732

10.1201/b12414-5

 

10.1039/C4OB02077D

10.1021/om201028q

10.1021/acs.inorgchem.7b02343

10.1016/j.jorganchem.2009.03.032

 

10.1016/j.jorganchem.2008.10.047

10.1002/adsc.201100183

10.1002/adsc.201000472

10.1021/acs.organomet.6b00023

10.1002/adsc.201401131

10.1002/chem.201200217

 

10.1002/ejic.200900964

10.1002/1521-3773(20001201)39:23<4237::AID-ANIE4237>3.0.CO;2-A

10.1002/1521-3757(20001201)112:23<4407::AID-ANGE4407>3.0.CO;2-K

10.1021/cr000436x

10.1021/ar400181x

10.1039/C5CS00721F

10.1021/jacs.5b01851

10.1016/j.jinorgbio.2017.06.010

10.1039/c1cs15123a

10.1002/cphc.201600239

10.1002/cctc.201700518

10.1002/chem.201703574

10.1039/C7DT02349A

10.1021/om100300a

10.1016/j.ica.2004.06.068

10.1039/b911234k

10.1016/j.bmc.2009.10.034

10.1039/c1dt10368g

10.1016/j.ica.2012.12.013

10.1039/C3DT52594E

10.1016/j.jinorgbio.2015.12.020

10.1016/j.ica.2016.03.012

10.1016/j.jinorgbio.2016.11.009

10.1016/j.jinorgbio.2017.08.020

10.1039/C6DT00865H

10.1039/C2CC37262B

10.1039/c3tc31168f

10.1002/zaac.200300247

10.1039/C5DT03930D

10.1002/anie.200353127

10.1002/ange.200353127

10.1070/RC1963v032n04ABEH001329

10.1021/ar500015k

10.1039/C1CS15182G

10.1016/S0009-2614(97)00100-0

10.1107/S0108768104020300

10.1007/BF00549096

10.1016/j.poly.2016.06.031

10.1016/j.jorganchem.2004.08.028

10.1038/nchem.1822

10.1039/b306004g

10.1039/c1cc14351d

10.1021/om0601706

10.1002/chem.201303744

10.1039/c3dt50434d

10.1002/ejic.200800167

10.1021/ic201741h

10.1021/ic300609f

10.1016/0047-2670(80)85060-X

10.1002/cmdc.200900370

10.1039/c2mt00083k

10.18632/oncotarget.21708

10.1002/rcm.6661

10.1007/s00018-015-2031-y

10.1158/2159-8290.CD-15-0011

10.1038/nrd3373

10.1021/bi00232a015

10.1016/B978-0-444-42607-9.50090-5

10.1039/jr9620001490

Rigaku Oxford Diffraction 2017 CrysAlisPro Version 1.171.38.43.

Bruker AXS BV Madison WI USA;1997–2004.

10.1016/S0076-6879(97)76066-X

10.1107/S0021889896014628

10.1107/S2053229614024218

10.1107/S0021889808042726

10.1039/B818330A

10.1515/dmdi-2013-0015

10.1039/C6DT03591D

10.1016/j.ica.2014.07.067

10.1016/j.jorganchem.2013.12.019

10.1002/asia.201301331

10.1016/j.omtn.2017.05.003

10.1038/nmeth.2019

10.1038/cddis.2012.171